Phase III, randomized study of trastuzumab emtansine (T-DM1) +/- pertuzumab (P) vs trastuzumab plus taxane (HT) for first-line treatment of HER2-positive MBC: Primary results from the MARIANNE study.

Affiliation auteurs!!!! Error affiliation !!!!
TitrePhase III, randomized study of trastuzumab emtansine (T-DM1) +/- pertuzumab (P) vs trastuzumab plus taxane (HT) for first-line treatment of HER2-positive MBC: Primary results from the MARIANNE study.
Type de publicationJournal Article
Year of Publication2015
AuteursEllis PAnthony, Barrios CH, Eiermann W, Toi M, Im Y-H, Conte PFranco, Martin M, Pienkowski T, Pivot XB, Burris HA, Strasak A, Patre M, Perez EA
JournalJOURNAL OF CLINICAL ONCOLOGY
Volume33
Date PublishedMAY 20
Type of ArticleMeeting Abstract
ISSN0732-183X
DOI10.1200/jco.2015.33.15_suppl.507